Vaccine Market Report by Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others), Patient Type (Pediatric, Adult), Indication (Bacterial Diseases, Viral Diseases), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, and Others), Product Type (Multivalent Vaccine, Monovalent Vaccine), Treatment Type (Preventive Vaccine, Therapeutic Vaccine), End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), and Region 2024-2032

<p>The global vaccine market size reached US$ 54.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 124.5 Billion by 2032, exhibiting a growth rate (CAGR) of 9.6% during 2024-2032. The implementation of stringent regulations promoting the adoption of vaccination among individuals, several advances in biotechnology and vaccine development techniques, and the growing health awareness among the population about the importance of vaccination are some of the major factors propelling the market.</p>

全球疫苗市场规模在2023年达到546亿美元。展望未来，IMARC集团预测该市场将于2032年增长至1245亿美元，在2024年至2032年期间展现出9.6%的复合年增长率。推动市场增长的主要因素包括严格法规的实施，这些法规促进了个人对疫苗接种的接受度，生物技术和疫苗研发技术的多项进展，以及公众对疫苗接种重要性认识的不断提高。